The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age

A quadrivalent meningococcal vaccine conjugated to CRM197 (MenACWY-CRM197) is immunogenic in young infants. We assessed the memory B-cell and antibody responses after a primary and booster course of MenACWY-CRM197 in children. At 5 months of age, following primary immunisation, serogroup-specific me...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Blanchard-Rohner, G, Snape, MD, Kelly, D, O'Connor, D, John, T, Clutterbuck, E, Ohene-Kena, B, Klinger, C, Odrljin, T, Pollard, A
Format: Journal article
Sprog:English
Udgivet: 2013